Carregant...
Time of infliximab therapy initiation and dose escalation in Crohn’s disease
AIM: To determine if early initiation of anti-tumor necrosis factor therapy affects the need for dose escalation. METHODS: This was a retrospective review of patients receiving infliximab therapy for Crohn’s disease (CD) at two outpatient gastroenterology clinics during July 2009 to October 2010. Al...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Baishideng Publishing Group Co., Limited
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3886010/ https://ncbi.nlm.nih.gov/pubmed/24415874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i1.214 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|